US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019
Stage-specific survival gains, reflecting treatment advances and improved access to cancer treatment from 2010 to 2019, resulted in an estimated 173 900 fewer cancer deaths among US cancer patients diagnosed during this time period.
Authors
- Anika T. Haque (ORCID: https://orcid.org/0000-0002-0619-9300)
- Ruth M. Pfeiffer (ORCID: https://orcid.org/0000-0001-7791-2698)
- Meredith S. Shiels (ORCID: https://orcid.org/0000-0001-8390-6091)
- Amy Berrington de González (ORCID: https://orcid.org/0000-0002-7332-8387)
- Stanley Lipkowitz (ORCID: https://orcid.org/0000-0002-6103-2255)
- Douglas R. Lowy (ORCID: https://orcid.org/0000-0003-0635-219X)
- Neal D. Freedman (ORCID: https://orcid.org/0000-0003-0074-1098)
Institutions
- Institute of Cancer Research (GB)
- Cancer Research UK (GB)
- Institute of Cancer Research (CA)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1093/jnci/djaf192
- Citations
- 4
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 4.18